SCHEMBL14360751

SCHEMBL14360751

Cc1oc(-c2cnco2)cc1-c1ccc(NC(=O)c2c(F)cccc2F)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IL2 P60568 13/20 0.51
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
IMPDH2 P12268 1/20 0.40
TP53 P04637 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP1A2 P05177 1/20 0.39
STIM1 Q13586 1/20 0.39
ORAI1 Q96D31 1/20 0.39
ORAI2 Q96SN7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2813178 0.85 IL2 (0.64) IL2NPC1RAB9AKDM4EALDH1A1
SCHEMBL2885792 0.83 IL2 (0.54) IL2NPC1RAB9AKDM4EALDH1A1
SCHEMBL5029603 0.80 IL2 (0.53) IL2NPC1RAB9AKDM4EALDH1A1
SCHEMBL5027346 0.77 IL2 (0.49) IL2NPC1RAB9AKDM4EALDH1A1
SCHEMBL12155839 0.76 IL2 (0.59) IL2NPC1RAB9AKDM4EALDH1A1
SCHEMBL2816403 0.74 IL2 (0.65) IL2NPC1RAB9ATP53SMN1; SMN2
SCHEMBL17052593 0.74 IL2 (0.52) IL2NPC1RAB9AKDM4EALDH1A1
SCHEMBL8239294 0.73 IL2 (0.67) IL2NPC1RAB9AKDM4EALDH1A1
SCHEMBL5033765 0.73 IL2 (0.45) IL2NPC1RAB9AKDM4EALDH1A1
SCHEMBL12155849 0.73 IL2 (0.58) IL2KDM4ETDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275960-A1 Phenyl and pyridyl compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2007-11-29 US disclosed
US-20070275960-A1 Phenyl and pyridyl compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275960-A1 Phenyl and pyridyl compounds for inflammation and immune-related uses NLRP3, CCR1, NLRP1 IL2 55/4885NPC1 636/4885RAB9A 2515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.